CVE-2015-2838

Public Exploit

Description

Cross-site request forgery (CSRF) vulnerability in Nitro API in Citrix NetScaler before 10.5 build 52.3nc allows remote attackers to hijack the authentication of administrators for requests that execute arbitrary commands as nsroot via shell metacharacters in the file_name JSON member in params/xen_hotfix/0 to nitro/v1/config/xen_hotfix.

Category

6.8
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 5.03% Top 15%
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://www.exploit-db.com/exploits/36442/ exploit
https://www.securify.nl/advisory/SFY20140806/command_injection_vulnerability_in_citrix_nitro_sdk_xen_hotfix_page.html exploit
http://packetstormsecurity.com/files/130937/Citrix-NITRO-SDK-Command-Injection.html exploit
http://www.securityfocus.com/archive/1/534936/100/0/threaded mailing list
http://www.securityfocus.com/bid/73358 vdb entry
http://seclists.org/fulldisclosure/2015/Mar/129 mailing list

Frequently Asked Questions

What is the severity of CVE-2015-2838?
CVE-2015-2838 has been scored as a medium severity vulnerability.
How to fix CVE-2015-2838?
To fix CVE-2015-2838, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2015-2838 being actively exploited in the wild?
It is possible that CVE-2015-2838 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~5% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.